Staburo is a member of BVMA
We haven’t announced it, but since mid of 2023, Staburo is a very proud member of the BVMA (Bundesverband Medizinischer Auftragsinstitute). We are very happy to be one of the 50 member companies and to join this diverse and highly qualified network. We look forward to exciting exchanges, to events and options to share our expertise and to learn from each other.
As an example, which topics are presented at BVMA events, we wrote a short summary about the last symposium:
For the first time as full member, Staburo Head of Quality Dr. Luciana Husfeld and Managing Directors Dr. Josef Höfler and Roland Stieger took part in the BVMA symposium on 24 November 2023, at the Holiday Inn City Centre Hotel in Munich. This year it was the 31. BVMA symposium and the get-together took place the evening before at the venue.
This year’s topic was: “Rethinking clinical research: From patients to AI”. The symposium presentations and discussions covered the areas of regulatory, experiences with CTR/CTIS and as well patient participation and AI applications within clinical research.
We were very happy to learn more about current changes in regulations and updates in the CRO market – thank you for the excellent networking sessions! Congratulations to the BVMA for the organization of this great event and thank you for the invitation! We are already looking forward to next BVMA symposium on 22nd of November 2024.
The BVMA represents the interests of its German CRO members. BVMA members maintain a lively exchange of information on topics that important to the German CRO industry, e.g. on questions of liability and insurance, education and training, quality requirements and trends in the pharmaceutical and CRO industry.